VPREB3 |
Q9UKI3
|
V-set pre-B cell surrogate light chain 3
|
Immune response
|
9.5E-02 |
0.821 |
0.192 |
IGHV3-75 |
|
immunoglobulin heavy variable 3-75 (pseudogene)
|
|
|
0.769 |
0.231 |
SERPINA9 |
Q86WD7
|
serpin family A member 9
|
Enzyme modulator
|
1.2E-13 |
0.769 |
0.231 |
FAU |
P35544
|
FAU ubiquitin like and ribosomal protein S30 fusion
|
|
0.85 |
0.792 |
0.269 |
MEF2B |
Q02080
|
myocyte enhancer factor 2B
|
|
9.3E-04 |
0.670 |
0.308 |
IGL |
|
immunoglobulin lambda locus
|
|
|
0.659 |
0.346 |
GCSAM |
Q8N6F7
|
germinal center associated signaling and motility
|
|
6.4E-02 |
0.705 |
0.346 |
PWWP3A |
Q2TAK8
|
PWWP domain containing 3A, DNA repair factor
|
|
2.2E-03 |
0.636 |
0.385 |
AFF1 |
P51825
|
AF4/FMR2 family member 1
|
Transcription factor
|
0.71 |
0.659 |
0.423 |
IGHV3-52 |
|
immunoglobulin heavy variable 3-52 (pseudogene)
|
|
|
0.674 |
0.423 |
RHOH |
Q15669
|
ras homolog family member H
|
Enzyme modulator
|
0.15 |
0.666 |
0.462 |
IGK |
|
immunoglobulin kappa locus
|
|
|
0.647 |
0.462 |
FCRL5 |
Q96RD9
|
Fc receptor like 5
|
Cell adhesion
|
4.6E-17 |
0.722 |
0.462 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
BCL2L2-PABPN1 |
Q92843
|
BCL2L2-PABPN1 readthrough
|
|
0.28 |
0.653 |
0.500 |
RANGAP1 |
P46060
|
Ran GTPase activating protein 1
|
Enzyme modulator
|
2.6E-02 |
0.617 |
0.538 |
CLEC4D |
Q8WXI8
|
C-type lectin domain family 4 member D
|
|
2.5E-06 |
0.587 |
0.538 |
CD79B |
P40259
|
CD79b molecule
|
Receptor
|
0.92 |
0.576 |
0.577 |
RTL10 |
Q7L3V2
|
retrotransposon Gag like 10
|
|
|
0.670 |
0.577 |
BCL2L2 |
Q92843
|
BCL2 like 2
|
Signaling
|
0.47 |
0.599 |
0.615 |
BCL9 |
O00512
|
BCL9 transcription coactivator
|
|
0.50 |
0.595 |
0.615 |
CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
FGR |
P09769
|
FGR proto-oncogene, Src family tyrosine kinase
|
Kinase
|
0.48 |
0.647 |
0.615 |
NPR2 |
P20594
|
natriuretic peptide receptor 2
|
Kinase
|
4.2E-05 |
0.573 |
0.615 |